Literature DB >> 23504348

BMP7 expression in esophageal squamous cell carcinoma and its potential role in modulating metastasis.

Guanghui Xu1, Shanhong Tang, Jianjun Yang, Kang Chen, Jianqin Kang, Guohong Zhao, Fan Feng, Xuewen Yang, Lina Zhao, Qun Lu, Li Sun, Liu Hong, Taiqian Gong, Hongwei Zhang.   

Abstract

BACKGROUND: Our previous study showed that BMP7 revealed significantly higher levels in esophageal squamous cell carcinoma (ESCC) tissues with lymph node metastasis compared with non-lymph node metastasis, using gene expression profiling assays. The roles of BMP7 in ESCC is not fully understood. AIM: The aim of this study was to investigate the effect of BMP7 on lymph node metastasis of ESCC and to explore its potential mechanism.
METHODS: Expression of BMP7 in ESCC tissues was evaluated by immunohistochemistry. BMP7 were down-regulated by RNA interference. The protein and mRNA levels of BMP7 were detected by western blot and RT-PCR, respectively. High content screening and transwell assay were used to identify the metastatic ability of tumor cells.
RESULTS: Positivity of BMP7 staining was 57.5 % in the tissues of primary carcinoma with lymph node metastasis compared to tissues without lymph node metastasis, and expression of BMP7 was significantly higher in the cell lines with highly metastatic capacity than that in the cell lines without metastatic ability. Suppression of endogenous BMP7 expression by siRNA in the highly metastatic cell lines resulted in significant reduction in ability of cell migration and invasion in both in vitro and in vivo studies. In addition, inhibition of BMP7 by siRNA also leads to up-regulation of E-cadherin and down-regulation of MMP-9 in the highly metastatic cell lines.
CONCLUSIONS: These findings indicate that BMP7 modulates the expression of E-cadherin and MMP-9, and by which mechanism it may regulate cell migration and metastasis of ESCCs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23504348     DOI: 10.1007/s10620-013-2611-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Expression of bone morphogenetic protein 7 in lung cancer and its biological impact on lung cancer cells.

Authors:  Jinfeng Chen; Lin Ye; Fei Xie; Yue Yang; Lijian Zhang; Wen G Jiang
Journal:  Anticancer Res       Date:  2010-04       Impact factor: 2.480

2.  Nuclear expression of Twist promotes lymphatic metastasis in esophageal squamous cell carcinoma.

Authors:  Taiqian Gong; Zengfu Xue; Shanhong Tang; Xiushan Zheng; Guanghui Xu; Liucun Gao; Guohong Zhao; Liu Hong; Guangbo Tang; Hongwei Zhang; Ruwen Wang; Yaoguang Jiang; Daiming Fan
Journal:  Cancer Biol Ther       Date:  2012-06-01       Impact factor: 4.742

3.  Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer.

Authors:  Emma-Leena Alarmo; Jenita Rauta; Päivikki Kauraniemi; Ritva Karhu; Tuula Kuukasjärvi; Anne Kallioniemi
Journal:  Genes Chromosomes Cancer       Date:  2006-04       Impact factor: 5.006

Review 4.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

5.  PI3K, Erk signaling in BMP7-induced epithelial-mesenchymal transition (EMT) of PC-3 prostate cancer cells in 2- and 3-dimensional cultures.

Authors:  Minyoung Lim; Cheng-Ming Chuong; Pradip Roy-Burman
Journal:  Horm Cancer       Date:  2011-10       Impact factor: 3.869

6.  Up-regulation of VEGF-C secreted by cancer cells and not VEGF-A correlates with clinical evaluation of lymph node metastasis in esophageal squamous cell carcinoma (ESCC).

Authors:  Malgorzata Krzystek-Korpacka; Malgorzata Matusiewicz; Dorota Diakowska; Krzysztof Grabowski; Katarzyna Blachut; Teresa Banas
Journal:  Cancer Lett       Date:  2006-09-29       Impact factor: 8.679

7.  BMP7 influences proliferation, migration, and invasion of breast cancer cells.

Authors:  Emma-Leena Alarmo; Jenita Pärssinen; Johanna M Ketolainen; Kimmo Savinainen; Ritva Karhu; Anne Kallioniemi
Journal:  Cancer Lett       Date:  2008-11-05       Impact factor: 8.679

8.  BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo.

Authors:  Jeroen T Buijs; Cyrill A Rentsch; Geertje van der Horst; Petra G M van Overveld; Antoinette Wetterwald; Ruth Schwaninger; Niek V Henriquez; Peter Ten Dijke; Fran Borovecki; Regula Markwalder; George N Thalmann; Socrates E Papapoulos; Rob C M Pelger; Slobodan Vukicevic; Marco G Cecchini; Clemens W G M Löwik; Gabri van der Pluijm
Journal:  Am J Pathol       Date:  2007-09       Impact factor: 4.307

9.  Bone morphogenetic proteins induce expression of metalloproteinases in melanoma cells and fibroblasts.

Authors:  Tanja Rothhammer; Simone Braig; Anja-Katrin Bosserhoff
Journal:  Eur J Cancer       Date:  2008-09-04       Impact factor: 9.162

10.  SDR9C7 promotes lymph node metastases in patients with esophageal squamous cell carcinoma.

Authors:  Shanhong Tang; Liucun Gao; Qian Bi; Guanghui Xu; Simeng Wang; Guohong Zhao; Zheng Chen; Xiushan Zheng; Yanglin Pan; Lina Zhao; Jianqin Kang; Guitao Yang; Yongquan Shi; Kaichun Wu; Taiqian Gong; Daiming Fan
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more
  9 in total

1.  Promoter hypomethylation of EpCAM-regulated bone morphogenetic protein gene family in recurrent endometrial cancer.

Authors:  Ya-Ting Hsu; Fei Gu; Yi-Wen Huang; Joseph Liu; Jianhua Ruan; Rui-Lan Huang; Chiou-Miin Wang; Chun-Liang Chen; Rohit R Jadhav; Hung-Cheng Lai; David G Mutch; Paul J Goodfellow; Ian M Thompson; Nameer B Kirma; Tim Hui-Ming Huang
Journal:  Clin Cancer Res       Date:  2013-09-27       Impact factor: 12.531

Review 2.  Bone Morphogenetic Protein Signaling in Cancer; Some Topics in the Recent 10 Years.

Authors:  Shogo Ehata; Kohei Miyazono
Journal:  Front Cell Dev Biol       Date:  2022-05-25

3.  MicroRNA-137 inhibits cell migration and invasion by targeting bone morphogenetic protein-7 (BMP7) in non-small cell lung cancer cells.

Authors:  Yan-Rong Yang; Yun-Xia Li; Xin-Yuan Gao; Sha-Sha Zhao; Shu-Zhi Zang; Zhi-Qiang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  Increased expression of HSP27 inhibits invasion and metastasis in human esophageal squamous cell carcinoma.

Authors:  Lin Xue; Lei Yang; Zhi-an Jin; Fei Gao; Jian-qin Kang; Guang-hui Xu; Bing Liu; Hong Li; Xiao-juan Wang; Li-juan Liu; Biao-luo Wang; Shu-hui Liang; Jie Ding
Journal:  Tumour Biol       Date:  2014-04-20

5.  BMP-7 enhances cell migration and αvβ3 integrin expression via a c-Src-dependent pathway in human chondrosarcoma cells.

Authors:  Jui-Chieh Chen; Shu-Ting Yang; Chih-Yang Lin; Chin-Jung Hsu; Chun-Hao Tsai; Jen-Liang Su; Chih-Hsin Tang
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

6.  Prognosis and Progression of ESCC Patients with Perineural Invasion.

Authors:  Guanghui Xu; Fan Feng; Zhen Liu; Shushang Liu; Gaozan Zheng; Shuao Xiao; Lei Cai; Xuewen Yang; Guocai Li; Xiao Lian; Man Guo; Li Sun; Jianjun Yang; Daiming Fan; Qun Lu; Hongwei Zhang
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

7.  Expression Of BMP7 In Ovarian Cancer And Biological Effect Of BMP7 Knockdown On Ovarian Cancer Cells.

Authors:  Hongwei Guan; Juan Li; Rui Sun; Wei Liu; Mei Feng; Hui Ma; Changzhong Li
Journal:  Onco Targets Ther       Date:  2019-09-26       Impact factor: 4.147

8.  Bone morphogenetic protein-7 expression reflects the high proliferative ability and aggressiveness of thymic epithelial tumors.

Authors:  Kentaro Miura; Kazutoshi Hamanaka; Tsuyoshi Uehara; Masanobu Momose; Yukiko Kanai; Shunichiro Matsuoka; Tetsu Takeda; Hiroyuki Agatsuma; Akira Hyogotani; Ken-Ichi Ito
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

9.  Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma.

Authors:  Ines Leinhäuser; Andrea Richter; Misu Lee; Ines Höfig; Nataša Anastasov; Falko Fend; Tonino Ercolino; Massimo Mannelli; Anne-Paule Gimenez-Roqueplo; Mercedes Robledo; Ronald de Krijger; Felix Beuschlein; Michael J Atkinson; Natalia S Pellegata
Journal:  Oncotarget       Date:  2015-11-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.